Indraprastha Medical Corporation Ltd vs Medinova Diagnostic Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Indraprastha Medical Corporation Ltd is ₹ 305.15 as of 30 Oct 15:30 . The P/E Ratio of Indraprastha Medical Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Medinova Diagnostic Services Ltd(Merged) changed from 11.3 on March 2021 to 20 on March 2025 . This represents a CAGR of 12.10% over 5 years The Market Cap of Indraprastha Medical Corporation Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Medinova Diagnostic Services Ltd(Merged) changed from ₹ 22.86 crore on March 2021 to ₹ 37.95 crore on March 2025 . This represents a CAGR of 10.67% over 5 years The revenue of Indraprastha Medical Corporation Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Medinova Diagnostic Services Ltd(Merged) for the Sep '25 is ₹ 2.53 crore as compare to the Jun '25 revenue of ₹ 2.78 crore. This represent the decline of -8.99% The ebitda of Indraprastha Medical Corporation Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Medinova Diagnostic Services Ltd(Merged) for the Sep '25 is ₹ 0.95 crore as compare to the Jun '25 ebitda of ₹ 1.11 crore. This represent the decline of -14.41% The net profit of Indraprastha Medical Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of 0.0% The net profit of Medinova Diagnostic Services Ltd(Merged) changed from ₹ 0.42 crore to ₹ 0.51 crore over 6 quarters. This represents a CAGR of 13.82% The Dividend Payout of Indraprastha Medical Corporation Ltd changed from 39.1 % on March 2022 to 19.97 % on March 2026 . This represents a CAGR of -12.57% over 5 yearsThe Dividend Payout of Medinova Diagnostic Services Ltd(Merged) changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Limited was incorporated on 16th March, 1988.
The main business of the Company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The Company was formed as a joint venture between the Government of Delhi and the Apollo Hospitals Group to establish the Indraprastha Apollo Hospitals. The Hospital provides international standard medical care, offering a wide range of multi-specialty services.
Key specialties with strong growth and revenue potential include transplants, cardiology, oncology, neurology, and orthopaedics. The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000.
IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi.

About Medinova Diagnostic Services Ltd

Medinova Diagnostic Services Limited (MDSL), incorporated in 1985, commenced business on 26 March, 1993.
It belongs to Standard Organics Group.
The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology. MDSL has acquired the business and undertaking of the diagnostic services division of Standard Medical & Pharmaceuticals (SMPL) as a going concern together with assets and liabilities from 1 Apr.'93.
It has four main diagnostic centres in Hyderabad, Bangalore, Pune, and Kolkata apart from mini/medium-sized franchise centres at Karimnagar, Mancherial, Vizag, Nellore. MDSL came out with a public issue of 67.50 lac equity shares at par, aggregating Rs 6.

FAQs for the comparison of Indraprastha Medical Corporation Ltd and null

Which company has a larger market capitalization, Indraprastha Medical Corporation Ltd or Medinova Diagnostic Services Ltd?

Market cap of Indraprastha Medical Corporation Ltd is 2,797 Cr while Market cap of Medinova Diagnostic Services Ltd is 43 Cr

What are the key factors driving the stock performance of Indraprastha Medical Corporation Ltd and Medinova Diagnostic Services Ltd?

The stock performance of Indraprastha Medical Corporation Ltd and Medinova Diagnostic Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indraprastha Medical Corporation Ltd and Medinova Diagnostic Services Ltd?

As of October 31, 2026, the Indraprastha Medical Corporation Ltd stock price is INR ₹305.15. On the other hand, Medinova Diagnostic Services Ltd stock price is INR ₹43.45.

How do dividend payouts of Indraprastha Medical Corporation Ltd and Medinova Diagnostic Services Ltd compare?

To compare the dividend payouts of Indraprastha Medical Corporation Ltd and Medinova Diagnostic Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.